Please use this identifier to cite or link to this item: http://hdl.handle.net/10400.17/2499
Title: Undetectable Levels of CSF Amyloid-β Peptide in a Patient with 17β-Hydroxysteroid Dehydrogenase Deficiency
Author: Ortez, C
Villar, C
Fons, C
Duarte, ST
Pérez, A
García-Villoria, J
Ribes, A
Ormazábal, A
Casado, M
Campistol, Jaume
Vilaseca, MA
García-Cazorla, A
Keywords: 17-Hydroxysteroid Dehydrogenases
Amyloid beta-Peptides
Biomarkers
Brain Diseases, Metabolic, Inborn
Child, Preschool
Fatal Outcome
Genes, X-Linked
Humans
Male
HDE NEU PED
Issue Date: 2011
Publisher: IOS Press
Citation: J Alzheimers Dis. 2011;27(2):253-7
Abstract: 17β-hydroxysteroid dehydrogenase 10 (HSD10) deficiency is a rare X-linked inborn error of isoleucine catabolism. Although this protein has been genetically implicated in Alzheimer's disease pathogenesis, studies of amyloid-β peptide (Aβ) in patients with HSD10 deficiency have not been previously reported. We found, in a severely affected child with HSD10 deficiency, undetectable levels of Aβ in the cerebrospinal fluid, together with low expression of brain-derived neurotrophic factor, α-synuclein, and serotonin metabolites. Confirmation of these findings in other patients would help elucidating mechanisms of synaptic dysfunction in this disease, and highlight the role of Aβ in both early and late periods of life.
Peer review: yes
URI: http://hdl.handle.net/10400.17/2499
DOI: 10.3233/JAD-2011-110647
Appears in Collections:NEU PED - Artigos

Files in This Item:
File Description SizeFormat 
J Alzheimer Dis 2011_27_253.pdf262,39 kBAdobe PDFView/Open


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.